Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.

[1]  C. Curry,et al.  Cardiovascular effects of dobutamine in severe congestive heart failure. , 1977, American heart journal.

[2]  J. S. Janicki,et al.  Cardiotonic agents in the management of chronic cardiac failure. , 1982, American heart journal.

[3]  J. Cohn,et al.  Hemodynamic effect of dobutamine in patients with severe heart failure. , 1975, The American journal of cardiology.

[4]  E. Braunwald,et al.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. , 1983, The New England journal of medicine.

[5]  E. Amsterdam,et al.  Hemodynamic Effects of Oral Pirbuterol in Chronic Severe Congestive Heart Failure , 1981, Circulation.

[6]  B. Pitt,et al.  Hemodynamic effects of intravenous prenalterol in severe heart failure. , 1981, The American journal of cardiology.

[7]  R. Magorien,et al.  Long-term benefit of dobutamine in patients with congestive cardiomyopathy. , 1980, American heart journal.

[8]  C. Leier,et al.  Tolerance to dobutamine after a 72 hour continuous infusion. , 1980, The American journal of medicine.

[9]  W. P. Reed,et al.  Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. , 1983, The American journal of cardiology.

[10]  E. Sonnenblick,et al.  Should the failing heart be stimulated? , 1984, The New England journal of medicine.

[11]  R. Magorien,et al.  The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy. , 1983, American heart journal.

[12]  E. Sonnenblick,et al.  Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure. , 1980, The American journal of cardiology.

[13]  C. Bush,et al.  The Cardiovascular Effects of the Continuous Infusion of Dobutamine in Patients with Severe Cardiac Failure , 1977, Circulation.

[14]  E. Sonnenblick,et al.  Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. , 1983, The American journal of cardiology.

[15]  B. Brundage,et al.  Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics. , 1981, The American journal of cardiology.

[16]  C. Leier,et al.  The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure. , 1979, The American journal of medicine.

[17]  R. D’angelo,et al.  Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure. , 1975, British heart journal.

[18]  C. Leier,et al.  Drug-induced conditioning in congestive heart failure. , 1982, Circulation.

[19]  C. Liang,et al.  Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. , 1984, Circulation.

[20]  P. L. Hamilton,et al.  Haemodynamic responses to dopamine and dobutamine infusions as a function of duration of infusion. , 1983, Pharmacology.